Laboratory for Nanomedicine and Imaging Sciences
Research in our laboratory involves areas of molecular imaging, drug delivery systems and nanomedicine and photoacoustic imaging. Our efforts are focused on three goals:
Develop targeted imaging probes for noninvasive characterization of molecular events associated with tumor progression and regression.
Multiple imaging modalities, including PET, SPETC, MRI and optical imaging are used to acquire complementary data with increased sensitivity and selectivity for early tumor detection, tumor-marker profiling and the monitoring of early treatment responses.
Develop novel drug-delivery systems for selective delivery of diagnostic and therapeutic agents to the disease sites.
Nanometric drug carriers are designed for selective delivery of anticancer agents to the tumor to maximize their therapeutic efficacy and minimize their toxic side effects to normal tissue. Our long-term goal is to apply the “seek and treat” strategy in the development of targeted imaging/ therapeutic agents that will eventually be translated to the clinic to improve the management of cancer through early tumor detection and individualized therapy.
Construct biological imaging based on the detection of acoustic waves induced by the absorption of short optical pulses in tissue.
We further plan to quantitatively detect intrinsic chromophores and exogenous contrast agents employing spectroscopic photoacoustic imaging.
The University of Texas MD Anderson Cancer Center
Department of Experimental Diagnostic Imaging -- Unit 0059
1515 Holcombe Blvd.
Houston, TX 77030
Lab Locations and Phone Numbers
- Y5: 713-745-3368
- Y7: 713-745-3369
- SB: 713-792-8738